IBRX - ImmunityBio, Inc.

$9.75 as of 2026-10-07 · Healthcare · Biotechnology · Stock

IBRX (ImmunityBio, Inc.) is the #788 most-held security of 3,193 tracked on Upside Invest, held by 3 retail investors (1% of tracked portfolios), at an average allocation of 1.2% of their portfolio.

• Popularity rank: #788 of 3,193
• Holders on Upside: 3 retail investors
• Average allocation: 1.2%
• Average holder gain/loss: +53.4%
• Stock grade: B
• 30-day trading activity: 0 buys / 0 sells
• Market cap: $7.1B

Related Healthcare securities: LLY, UNH, JNJ, MRK, HIMS

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.